secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2026-02-18T23:59:59+00:00
Accession:  0001664710-26-000005
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros Therapeutics CEO to present at three healthcare conferences in Feb-Mar 2026
--------------------------------------------------------------------------------

- Oppenheimer 36th Annual Healthcare Life Sciences Conference on Feb 25, 2026 at 11:20 a.m. ET (corporate presentation).
- TD Cowen 46th Annual Health Care Conference on Mar 3, 2026 at 9:50 a.m. ET (fireside chat).
- Leerink Partners Global Healthcare Conference on Mar 10, 2026 at 1:00 p.m. ET (fireside chat).
- Archived replays available on Keros website for up to 90 days after each event.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471026000005/0001664710-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471026000005/kros-20260218.htm
  HTML page:      https://secwatch.observer/filing/0001664710-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer